Olmesartan
51 interactions 1 explained in plain English 98 cited referencesOlmesartan is an angiotensin II receptor antagonist used to treat high blood pressure in adults and children. Read the full Olmesartan drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Olmesartan Aliskiren Tekturna An increased risk of hyperkalemia, renal impairment, and hypotension DetailsMajor
Olmesartan Lisinopril Prinivil Explained Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Olmesartan Benazepril Lotensin Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Olmesartan Captopril Capoten® Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Olmesartan Cyclosporine Injection Atopica An increased risk of hyperkalemia Details Olmesartan Cyclosporine Ophthalmic Cequa An increased risk of hyperkalemia Details Olmesartan Digoxin Cardoxin® An increased digoxin exposure Details Olmesartan Enalapril Epaned Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Olmesartan Fosinopril Monopril® Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Olmesartan Furosemide Injection Disal Severe hypotension and deterioration in renal function, including renal failure Details Olmesartan Moexipril Univasc® Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Olmesartan Lithium Increased risk of lithium toxicity Details Olmesartan Trimethoprim Primsol Increased risk of hyperkalemia Details Olmesartan Perindopril Aceon Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) DetailsModerate
Olmesartan Asenapine Transdermal Patch Secuado An increased risk of hypotension Details Olmesartan Bromfenac Ophthalmic Bromday® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Diclofenac Ophthalmic Voltaren® Eye Drops Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Diclofenac Topical (Actinic Keratosis) Pennsaid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Diclofenac Topical (Arthritis Pain) Pennsaid® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Diclofenac Transdermal Patch Flector Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Etodolac Lodine Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Fenoprofen Fenopron Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Flurbiprofen Ansaid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Flurbiprofen Ophthalmic Ocufen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Ibuprofen Addaprin Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) Increased risk of hypoglycemia Details Olmesartan Insulin Detemir (Rdna Origin) Injection Levemir Increased risk of hypoglycemia Details Olmesartan Insulin Glulisine (Rdna Origin) Injection Apidra Increased risk of hypoglycemia Details Olmesartan Ketoprofen Actron® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Ketorolac Acular Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Ketorolac Injection Acular Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Ketorolac Nasal Spray Sprix Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Ketorolac Ophthalmic Acular Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Meclofenamate Meclodium® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Mefenamic Acid Ponstel® Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Meloxicam Alloxate Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Meloxicam Injection Alloxate Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Nabumetone Relafen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Naproxen Aleve Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Olmesartan Colesevelam Welchol Decreased olmesartan medoxomil exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist